{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T01:09:56Z","timestamp":1780794596365,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.cllc.2016.01.005","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T15:27:23Z","timestamp":1454426843000},"page":"e31-e43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non\u2013Small-Cell Lung Cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"In-Ho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9954-8583","authenticated-orcid":false,"given":"Kyo-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-4504","authenticated-orcid":false,"given":"Young Kyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sook Whan","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Kil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeon Sil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Oh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2016.01.005_bib1","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cllc.2016.01.005_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3727\/096504014X14024160459168","article-title":"Adjuvant chemotherapy with sequential cytokine-induced killer (CIK) cells in stage IB non-small cell lung cancer","volume":"22","author":"Li","year":"2015","journal-title":"Oncol Res"},{"key":"10.1016\/j.cllc.2016.01.005_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/annonc\/mdv008","article-title":"Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer\u00a0\u22654 cm in size: an SEER-Medicare analysis","volume":"26","author":"Malhotra","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa031644","article-title":"Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer","volume":"350","author":"Arriagada","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.01.005_bib5","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1056\/NEJMoa043623","article-title":"Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer","volume":"352","author":"Winton","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2016.01.005_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib7","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"Pignon","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1200\/JCO.2009.24.0333","article-title":"Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10","volume":"28","author":"Butts","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib9","first-page":"191","article-title":"Adjuvant chemotherapy in non-small cell lung cancer: state-of-the-art","volume":"4","author":"Artal Cortes","year":"2015","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.cllc.2016.01.005_bib10","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","article-title":"Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups","volume":"26","author":"Strauss","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1749-8090-8-151","article-title":"Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer","volume":"8","author":"Park","year":"2013","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2016.01.005_bib12","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.6004\/jnccn.2014.0176","article-title":"Non-small cell lung cancer, version 1.2015","volume":"12","author":"Ettinger","year":"2014","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.cllc.2016.01.005_bib13","doi-asserted-by":"crossref","first-page":"e1337","DOI":"10.1097\/MD.0000000000001337","article-title":"Recurrence risk factors analysis for stage I non-small cell lung cancer","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cllc.2016.01.005_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/JTO.0000000000000480","article-title":"Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung","volume":"10","author":"Kinoshita","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib15","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ejcts\/ezu410","article-title":"Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resectiondagger","volume":"47","author":"Guerrera","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cllc.2016.01.005_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cllc.2015.02.008","article-title":"Improving the care of patients with stage IB non-small-cell lung cancer: role of prognostic signatures and use of cell cycle progression biomarkers","volume":"16","author":"Bunn","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2016.01.005_bib17","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11864-014-0313-5","article-title":"C-MET inhibitors in the treatment of lung cancer","volume":"15","author":"Gozdzik-Spychalska","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/gcc.20604","article-title":"Expression and mutational analysis of MET in human solid cancers","volume":"47","author":"Ma","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cllc.2016.01.005_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/JTO.0b013e318241655f","article-title":"c-MET\/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas","volume":"7","author":"Tsuta","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/JTO.0000000000000105","article-title":"MET expression plays differing roles in non-small-cell lung cancer patients with or without EGFR mutation","volume":"9","author":"Huang","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib21","first-page":"1","article-title":"Health behaviors of adults: United States, 2005-2007","volume":"10","author":"Schoenborn","year":"2010","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.cllc.2016.01.005_bib22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1369\/jhc.2008.950790","article-title":"Immunohistochemical method identifies lymphovascular invasion in a majority of oral squamous cell carcinomas and discriminates between blood and lymphatic vessel invasion","volume":"56","author":"O'Donnell","year":"2008","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.cllc.2016.01.005_bib23","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.athoracsur.2013.03.085","article-title":"Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size","volume":"95","author":"David","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2016.01.005_bib24","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2012.47.4189","article-title":"Randomized phase II trial of onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer","volume":"31","author":"Spigel","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2015.0071","article-title":"Non-small cell lung cancer, Version 6.2015","volume":"13","author":"Ettinger","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.cllc.2016.01.005_bib26","first-page":"1420","article-title":"Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence","volume":"6","author":"Park","year":"2014","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.cllc.2016.01.005_bib27","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jtcvs.2004.11.021","article-title":"Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer","volume":"130","author":"Shimizu","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2016.01.005_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jjco\/hyr188","article-title":"Differences between squamous cell carcinoma and adenocarcinoma of the lung: are adenocarcinoma and squamous cell carcinoma prognostically equal?","volume":"42","author":"Kawase","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib29","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0b013e31822573f5","article-title":"Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34","volume":"35","author":"Rose","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cllc.2016.01.005_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0218492313478431","article-title":"Prognostic impact of vascular and lymphovascular invasion in early lung cancer","volume":"22","author":"Al-Alao","year":"2014","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.cllc.2016.01.005_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1023768811842","article-title":"c-Met: structure, functions and potential for therapeutic inhibition","volume":"22","author":"Ma","year":"2003","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cllc.2016.01.005_bib32","first-page":"197","article-title":"High MET copy number and MET overexpression: poor outcome in non-small cell lung cancer patients","volume":"27","author":"Park","year":"2012","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.cllc.2016.01.005_bib33","first-page":"220","article-title":"Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer","volume":"27","author":"Sun","year":"2013","journal-title":"J\u00a0Biomed Res"},{"key":"10.1016\/j.cllc.2016.01.005_bib34","doi-asserted-by":"crossref","first-page":"e99399","DOI":"10.1371\/journal.pone.0099399","article-title":"Prognostic value of MET gene copy number and protein expression in patients with surgically resected non-small cell lung cancer: a meta-analysis of published literatures","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2016.01.005_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/JTO.0b013e3181ce3d1d","article-title":"High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer","volume":"5","author":"Go","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12885-015-1662-6","article-title":"c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence","volume":"15","author":"Al-Maghrabi","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cllc.2016.01.005_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1200\/JCO.2015.63.4600","article-title":"MET exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-MET overexpression","volume":"34","author":"Awad","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib38","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/JTO.0b013e3182519a42","article-title":"Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy","volume":"7","author":"Higgins","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/JTO.0b013e31824cbad8","article-title":"Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer","volume":"7","author":"Hung","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib40","article-title":"Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: implications for surveillance","author":"Spratt","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2016.01.005_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/annonc\/mds274","article-title":"Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy","volume":"24","author":"Lopez Guerra","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.01.005_bib42","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1002\/cncr.24625","article-title":"Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients","volume":"115","author":"Kelsey","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2016.01.005_bib43","first-page":"791","article-title":"Risk factors for recurrence in patients with resected N1 non-small cell lung cancer - a systematic review and meta-analysis","volume":"20","author":"Luo","year":"2015","journal-title":"J\u00a0BUON"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041630002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041630002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:07:16Z","timestamp":1761505636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573041630002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S152573041630002X"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2016.01.005","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2016.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}